Fetal cells may hold key to healing chronic wounds
NCT ID NCT06031714
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at fetal cells that remain in a mother's blood after pregnancy, called fetal microchimeric cells, in women with chronic skin ulcers like venous or diabetic ulcers. Researchers will analyze these cells' genetic activity to see if they might help with wound healing. The goal is to gather information that could lead to future treatments, not to test a therapy now.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new treatments for chronic skin ulcers by harnessing fetal cells.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not lead to any direct therapy, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC ULCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dermatology unit - Cochin Hospital - APHP
RECRUITINGParis, Île-de-France Region, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study to reveal best visiting policies for new Moms' mental health
- Blood thinners after birth: could they save lives of new moms at moderate risk?
- Sound waves and gel team up to heal stubborn leg ulcers
- New stent study aims to open blocked veins and heal leg ulcers
- Heel-Free bandage may be more comfortable for leg ulcer patients
- New dressing shows promise for Hard-to-Heal wounds